Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C. Kurz, Erik P. Sulman, Elçin Zan et al.|Clinical Cancer Research|2023Cited by 55
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Debra Hawes, Abed Rahman Kawakibi et al.|Cancer Discovery|2025Cited by 2
Data from Evaluation of the SSTR2-targeted Radiopharmaceutical <sup>177</sup>Lu-DOTATATE and SSTR2-specific <sup>68</sup>Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C. Kurz, Erik P. Sulman, Marissa Barbaro et al.|Unknown|2024Cited by 1
GENE-16. CLINICALLY AGGRESSIVE MENINGIOMAS ARE CHARACTERIZED BY MUTATIONAL SIGNATURES ASSOCIATED WITH DEFECTIVE DNA REPAIR AND MUTATIONS IN CHROMATIN REMODELING GENESSylvia C. Kurz, Matija Snuderl, Benjamin Liechty et al.|Neuro-Oncology|2018Cited by 0
Data from Evaluation of the SSTR2-targeted Radiopharmaceutical <sup>177</sup>Lu-DOTATATE and SSTR2-specific <sup>68</sup>Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C. Kurz, Erik P. Sulman, Elçin Zan et al.|Unknown|2024Cited by 0